Regulation of Autoimmune Diabetes by Complete Freund's Adjuvant Is Mediated by NK Cells

Journal of Immunology

Volumn 172, Issue 2, 2004, Pages 937-942

  Lee, I Fang ^a   Qin, Huilian ^a   Trudeau, Jacqueline ^a   Dutz, Jan ^a   Tan, Rusung ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIGEN DX5; CD3 ANTIGEN; CELL MARKER; FREUND ADJUVANT; GANGLIOTETRAOSYLCERAMIDE; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; FEMALE; IMMUNIZATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTECTION; SCID MOUSE;

EID: 1642454721     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.2.937     Document Type: Article

References (30)

1. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85:291.
2. Delovitch, T. L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity 7:727.
3. Sadelain, M. W., H. Y. Qin, J. Lauzon, and B. Singh. 1990. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:583.
4. McInerney, M. F., S. B. Pek, and D. W. Thomas. 1991. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 40:715.
5. Sadelain, M. W., H. Y. Qin, W. Sumoski, N. Parfrey, B. Singh, and A. Rabinovitch. 1990. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J. Autoimmun. 3:671.
6. Qin, H. Y., M. W. Sadelain, C. Hitchon, J. Lauzon, and B. Singh. 1993. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150:2072.
7. Lakey, J. R., T. Wang, G. L. Warnock, B. Singh, and R. V. Rajotte. 1992. Prevention of recurrence of insulin-dependent diabetes mellitus in islet cell-transplanted diahetic NOD mice using adjuvant therapy. Transplant Proc. 24:2848.
8. Qin, H. Y., and B. Singh. 1997. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclo-phosphamide. J. Autoimmun. 10:271.
9. Mathis, D., L. Vence, and C. Benoist. 2001. β-cell death during progression to diabetes. Nature 414:792.
10. DiLorenzo, T. P., R. T. Graser, T. Ono, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 1998. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95:12538.
11. + T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 96:9311.
12. Trudeau, J., C. Kelly-Smith, C. B. Verchere, J. F. Elliott, J. P. Dutz, D. T. Finegood, P. Santamaria, and R. Tan. 2003. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111:217.
13. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1663.
14. Karaoka, S., J. Satoh, H. Fujiya, T. Toyota, R. Suzuki, K. Itoh, and K. Kumagai. 1983. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32:247.
15. Shutlz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott. I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, D. L. Greiner, et al. 1995. Multiple defects in innale and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:180.
16. Shi, F. D., H. B. Wang, H. Li, S. Hong, M. Taniguchi, H. Link, L. Van Kaer, and H. G. Ljunggren. 2000. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nay. Immunol. 1:245.
17. Wicker, L. S., B. J. Miller, and Y. Mullen. 1986. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35:855.
18. Kim, S., K. Iizulka, H. S. Kang, A. Dokun, A. R. French, S. Greco, and W. M. Yokoyama. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3:523.
19. Baloni, G., S. Esin, M. Pardini, D. Bottai, S. Senesi, H. Wigzell, and M. Campa. 2000. Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille Calmette-Guerin (BCG). Clin. Exp. Immunol. 119:270.
20. Inaba, K., M. Inaba, M. Naito, and R. M. Steinman. 1993. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms. and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479.
21. Thurnher, M., R. Ramoner, G. Gastl, C. Radmayr, G. Bock, M. Herold, H. Klocker, and G. Bartsch. 1997. Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells. Int. J. Cancer 70:128.
22. Namnov, Y. N., K. S. Bahjat, R. Gausling, R. Abraham, M. A. Exley, Y. Koezuka, S. B. Balk, J. L. Strominger, M. Clare-Salzer, and S. B. Wilson. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98:13838.
23. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647.
24. Zitvogel, L. 2002. Dendritic and natural killer cells cooperate in the control/ switch of innate immunity. J. Exp. Med. 195:9.
25. Chambers, B. J., J. L. Wilson, M. Salcedo, K. Markovic, M. T. Bejarano, and H. G. Ljunggren. 1998. Triggering of natural killer cell mediated cytotoxicity by costimulatory molecules. Curr. Top. Microbiol. Immunol. 230:53.
26. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327.
27. Ogasawara, K., J. A. Hamerman, H. Hsin, S. Chikuma, H. Bour-Jordan, T. Chen, T. Pertel, C. Carnaud, J. A. Bluestone, and L. L. Lanier. 2003. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity. 18:41.
28. Negishi, K., N. Waldeck, G. Chandy, B. Buckingham, A. Kershnar, L. Fisher, S. Gupta, and M. A. Charles. 1986. Natural killer cell and islet killer cell activities in type I (insulin-dependent) diabetes. Diabetologia 29:352.
29. Herold, K. C., A. Huen, L. Gould, H. Traisman, and A. H. Rubenstein. 1984. Alternations in lymphocyte subpopulations in type I (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena. Diabetologia 27 (Suppl.):102.
30. Pozzilli, P., M. Sensi, L. Al-Tarn, O. Zuccarini, and G. F. Bottazzo. 1984. Prospective study of lymphocyte subsets in subjects genetically subceptible to type I (insulin-dependent) diabetes. Diabetologia 27 (Suppl.):132.